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Abstract
Background:  Experimental evidence supports the hypothesis that persistent organochlorine
pollutants (POPs) may cause type 2 diabetes mellitus, whereas there is no fully convincing
epidemiological evidence for such an association. In Sweden the most important source of POP
exposure is fatty fish. We have assessed the association between serum levels of POPs and
prevalence of diabetes in Swedish fishermen and their wives, with high consumption of fatty fish
from the Baltic Sea.
Methods: In 196 men (median age 60 years) and 184 women (median age 64 years), we analyzed
2,2',4,4',5,5'-hexachlorobiphenyl (CB-153) and 1,1-dichloro-2,2-bis(p-chlorophenyl)-ethylene (p,p'-
DDE) in serum using gas chromatography-mass spectrometry. The participants were asked if they
had diabetes and, if so, since which year and about medication and diet. The Odds Ratios (OR) for
diabetes with respect to continuous exposure variables were analyzed with logistic regression,
adjusting for potential confounders. Moreover trends of diabetes prevalence with respect to
trichotomized exposure variables were tested with Jonckheere-Terpstra's test.
Results: Six percent of the men and 5% of the women had diabetes. After confounder adjustment
CB-153 was significantly associated with diabetes prevalence using both categorized and
continuous exposure data (an increase of 100 ng/g lipid corresponded to an OR of 1.16, 95%
confidence interval [CI] 1.03, 1.32, p = 0.03). Similar associations were observed for p,p'-DDE (an
increase of 100 ng/g lipid corresponded to an OR of 1.05, 95% CI 1.01, 1.09, p = 0.006). Gender
stratified analyses showed among men consistent positive associations with CB-153, but a more
ambiguous pattern with respect to DDE. In contrast, among the women the associations with p,p'-
DDE were stronger than with CB-153.
Conclusion: The study provides support that POP exposure might contribute to type 2 diabetes
mellitus.
Introduction
It is widely believed that the increase in incidence of type
2 diabetes mellitus (T2DM) and obesity is the result of a
complex interplay between genetic and environmental
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factors [1]. T2DM is due to resistance to insulin action and
a relative deficiency of insulin. Age, obesity, central adi-
posity, lack of physical activity, dietary glycemic load, as
well as certain genotypic variants are the main factors
identified as responsible for the disease [2,3].
Exposure to dioxin has been linked to drastic reductions
in glucose uptake in guinea pigs, mice and rats, in vivo as
well as in vitro [4], leading to speculation that chronic low-
level exposure to dioxins might be a risk factor for T2DM
[5].
Previous epidemiological studies have recently been
reviewed [6]. Several studies have linked high dioxin bur-
dens to increased risks of T2DM or modified glucose
metabolism [7-10]. A Belgian study published later
showed highly significant elevation of serum levels of
dioxins and polychlorinated biphenyls (PCBs) among
patients with type T2DM [11]. Moreover, also chlorinated
insecticides have been associated with T2DM. In a group
of pesticide users and an unexposed group, Morgan et al
[12] found that subjects with T2DM had higher blood lev-
els of dichlorodiphenyl trichloroethane (DDT) and 1,1-
dichloro-2,2-bis(p-chlorophenyl)-ethylene (p,p'-DDE),
which is the major metabolite of DDT.
A major difficulty in these studies is, however, that expo-
sure occurred sometimes many years before the epidemi-
ologic study, which makes it difficult to determine
whether the higher serum levels of persistent organochlo-
rine pollutants (POPs) in diabetics truly reflect a higher
exposure to these pollutants, which in turn may contrib-
ute to diabetogenesis, or whether they are merely the con-
sequence of T2DM-induced metabolic perturbations
facilitating the accumulation of these pollutants. Thus, the
possibility of a reversed causality cannot be excluded.
In Sweden, consumption of fatty fish from the Baltic Sea,
off the Swedish east coast, is the single major exposure
source for POPs, and cohorts of professional fishermen
and their families from the Swedish east coast have been
found to constitute excellent study bases for epidemiolog-
ical evaluations of human health effects of POPs [13,14].
We have chosen to use 2,2',4,4',5,5'-hexachlorobiphenyl
(CB-153) as a biomarker for POP exposure, because it cor-
relates very well (r ≥ 0.98) with both total PCB concentra-
tion in plasma and serum from Swedish subjects [15,16]
and with the 2,3,7,8-tetrachlorodibenzo-p-dioxin
(TCDD) toxic equivalent (TEQ) in plasma from PCB (r =
0.89) as well as the total POP derived TEQ (r = 0.74) in
plasma in American Vietnam veterans [17]. Another rele-
vant exposure biomarker is the anti-androgenic com-
pound p,p'-DDE.
The aim of the present study was to assess the associations
between biomarkers for POP and prevalence of diabetes
Table 1: Characteristics for the 196 men and 184 women from Sweden that participated in the study
Men Women
Diabetes Diabetes
No (n = 184) Yes (n = 12) No (n = 174) Yes (n = 10)
Mean, median
(5th, 95th%)
Mean, median
(5th, 95th%)
Mean, median
(5th, 95th%)
Mean, median 
(5th, 95th%)
Age (yr)
Current 60, 59
(49, 75)
60, 60
(53, 67)
63, 61
(51, 77)
64, 64 
(51, 74)
At diagnosis - 52, 52
(30, 62)
-5 5 ,  5 6
(45, 65)
Time since diagnosis (yr) - 9, 5
(2, 26)
-1 0 ,  1 0
(0, 27)
Body Mass Index (kg/m2)
Current 28.6, 28.1
(23.5, 35.5)
29.4, 30.1
(22.4, 33.3)
27.9, 27.2
(21.3, 35.8)
30.4, 29.5
(26.6, 41.3)
At 25 years of age 23.4, 24.0
(20.0, 28.9)
26.0, 25.4
(21.3, 32.6)
22.0, 22.0 
(17.9, 26.6)
23.0, 22.5 
(19.7, 26.6)
Exposure (ng/g lipid)
CB-153 430, 360 
(110, 950)
670, 560 
(360, 1600)
280, 240
(94, 620)
300, 230 
(110, 810)
p,p'-DDE 800, 570
(110, 2100)
1100, 1100 
(390, 2400)
800, 590
(100, 2300)
1600, 990
(300, 5300)Environmental Health: A Global Access Science Source 2005, 4:28 http://www.ehjournal.net/content/4/1/28
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in high exposure cohorts of middle-aged and elderly men
and women. The results showed an association between
the POP markers in serum and prevalence of diabetes.
Methods
Study population and interview
Previously established cohorts of professional fishermen
and their wives from the Swedish east coast [14,18] were
linked to the Swedish Population Register. A postal ques-
tionnaire was sent in year 2000 to 1500 fishermen and
1291 fishermen's wives that were born between 1920 and
1954, living in Sweden and still alive at 31 December
1999 [28]. There were 813 men (54%) and 779 women
(77%) who responded to the questionnaire. Out of them
510 men and 596 women were positive to participate in
future clinical studies. We invited a subset of them to a
study mainly focused on bone mineral density [11], but
also comprising other potential health effects of POP
exposure. The aim was to include 200 men and 200
women in the study, and we consecutively contacted sub-
jects by phone for agreements until enough subjects were
recruited. Details of the recruitment process have been
given elsewhere [19]. The final study groups comprised
196 men and 184 women.
The participants were interviewed, using a standardized
questionnaire. The subjects were asked if they had diabe-
tes and, if so, since which year. Moreover, they were asked
if they had per oral antidiabetic drugs, insulin or were on
diet. We measured current weight and height. In addition,
they were asked about their weight at the age of 25 years.
Descriptive data for the participants are shown in Table 1.
Out of the group of 813 men that responded to the ques-
tionnaire there were 617 subjects that did not participate
in the clinical examination. The non-participants had sim-
ilar age distribution (median 62 years, range 49–84) as
the 196 participants (median 60, range 49–84). In addi-
tion, the BMI distributions were also very similar among
the non-participants (median 26.5 kg/m2, range 17.1–
39.9) and the participants (median 27.2, range 20.5–
38.5). Out of the group of 779 women that responded to
the questionnaire there were 595 subjects that did not par-
ticipate in the clinical examination. There was neither any
difference between the non-participating women and the
184 participants with respect to age (median 65 years,
range 49–84 versus median 64 years, range 49–83) or BMI
(median 26.5 kg/m2, range 17.1–39.9 versus median 26.2
kg/m2, range 19.7–38.2).
The study was performed in accordance with the Declara-
tion of Helsinki and approved by The Lund University
Ethic's Committee. All participants provided written
informed consents.
Blood sampling
Venous blood samples were drawn between 8.00 and
10.00 A.M, after 12 hr fasting, into sterile Vacutainer glass
tubes (BD Vacutainer, Plymouth, UK). Serum was sepa-
rated by centrifugation (4000 rpm, 10 minutes) and trans-
ferred to glass bottles and special tubes. All serum samples
were stored at -80°C until analysis.
Determination of CB-153 and p,p'-DDE in serum
The analyses were performed applying solid phase extrac-
tion using on-column degradation of the lipids and anal-
ysis by gas chromatography mass spectrometry as
previously described [20-22]. Levels of detection, coeffi-
cients of variation and participation in quality control
programs have been described in detail elsewhere [22].
Determination of serum lipids by enzymatic methods
Serum concentrations of triglycerides and cholesterol
were determined by enzymatic methods as described else-
where [22]. The total lipid concentration in serum (g/L)
was calculated by the following equations [23]:
Men: Total = 0.96 + 1.28*(triglycerides + cholesterol)
Women: Total = 1.13 + 1.31*(triglycerides + cholesterol).
Statistics
The effect estimations (odds ratios, OR) between the
exposure variables CB-153 and p,p'-DDE, respectively,
and diabetes were obtained from logistic regressions. The
exposure variables were treated as continuous variables.
Due to the high correlation between CB-153 and p,p'-
DDE (women r = 0.68; men r = 0.64) these variables were
not included in the models simultaneously. As potential
confounders we considered gender, current age (as con-
tinuous variable) and BMI at 25 years of age (as continu-
ous variable). In addition, the exposure variables were
categorized into three equally sized groups. For evaluation
whether there were trends in the data with respect to prev-
alence of diabetes, Jonckheere-Terpstra test (StatXact Sta-
tistical Software) was applied. Moreover, separate
analyses were performed for men and women. We did
also test whether time elapsed since diagnosis of diabetes
were correlated (Spearman's correlation test) with the
exposure variables and age.
Results
Twelve of the 196 men (6%) and 10 of the 184 women
(5%) had diabetes. Five of the male diabetics had per oral
antidiabetic drugs, two had a combination of per oral
drugs and insulin, one had insulin only, and the remain-
ing four were only on a diet. The corresponding figures for
the female diabetics were four, two, one and three, respec-
tively.Environmental Health: A Global Access Science Source 2005, 4:28 http://www.ehjournal.net/content/4/1/28
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For the whole data set CB-153 was significantly associated
with diabetes (an increase of 100 ng/g lipid corresponded
to an OR of 1.16, 95% confidence interval [CI] 1.03, 1.32,
p = 0.03). Among the men the corresponding OR was 1.20
(95% CI 1.04, 1.39, p = 0.01) and among the women 1.06
(95% CI 0.75, 1.50, p = 0.74). Regarding p,p'-DDE, there
was for the whole data set a significant association
between exposure and diabetes (an increase of 100 ng/g
lipid corresponded to an OR of 1.05, 95% CI 1.01, 1.09,
p = 0.006). The corresponding ORs were for the men 1.05
(95% CI 0.98, 1.11, p = 0.14) and for the women 1.05
(95% CI 1.01, 1.10, p = 0.02). None of the ORs changed
more than marginally (<3%) by including the potential
confounders. Moreover, excluding the two subjects with
insulin only therapy changed the risk estimates <1%.
Using the exposure data categorized into tertiles there
were for the whole data set significant positive trends
between CB-153 and p,p'-DDE exposure, respectively,
and diabetes (Table 2). Among the men significant posi-
tive trends between CB-153 exposure and diabetes (p =
0.005) and between p,p'-DDE exposure and diabetes (p =
0.04) were observed. Among the women the pattern was
very similar regarding p,p'-DDE exposure and diabetes (p
= 0.07), whereas no such association was observed for the
CB-153 exposure.
Time elapsed since diagnosis of diabetes was among the
men negatively correlated with CB-153 exposure (rs = -
0.59, p = 0.04), whereas it tended to be positively corre-
lated among the women (rs = 0.53, p = 0.12).
Discussion
The main finding of the present study was that diabetics
had significantly higher serum levels of both CB-153 and
p,p'-DDE than non-diabetic control subjects, using both
continuous and categorized exposure data. Gender strati-
fied analyses showed among men consistent positive
associations with CB-153, but a more ambiguous pattern
with respect to DDE. In contrast, among the women the
associations with p,p'-DDE were stronger than with CB-
153. We have no biological explanation for this gender
difference, which might be a random finding considering
the relatively small size of the study.
Our overall results are in concordance with a number of
previous epidemiological studies showing associations
between T2DM and dioxin exposure [7-10], but also with
PCB [11] and DDT/DDE [12] exposures. The epidemio-
logical findings have some biological plausibility as
TCDD in experimental studies of guinea pigs, mice and
rats decreases cellular glucose uptake [4]. Moreover, it has
recently been hypothesized that dioxins and dioxin-like
PCBs could promote T2DM by interaction with peroxi-
some proliferators-activated receptor-γ, a ligand-activated
transcription factor controlling lipid metabolism and
homeostasis that is linked with T2DM [5,24]. There are no
experimental data supporting that di-ortho PCB conge-
Table 2: Prevalence of diabetes in relation to tertiles of CB-153 and p,p'-DDE in serum.
Gender Diabetes p for trend a
Exposure (ng/g lipid) Yes/No
Male
CB-153
-290 0/64
>290–475 4/61 0.005
>475 8/58
p,p'-DDE
-410 1/63
>410–850 4/61 0.04
>850 7/60
Female
CB-153
-180 3/57
>180–290 4/57 0.94
>290 3/60
p,p'-DDE
-375 1/59
>375–860 3/59 0.07
>860 6/56
a Jonckheere-Terpstra's testEnvironmental Health: A Global Access Science Source 2005, 4:28 http://www.ehjournal.net/content/4/1/28
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ners such as CB-153, will have a diabetogenic effect by
themselves, but CB-153 serves as a good proxy marker
also for TCDD TEQ and the total POP derived TEQ.
An obvious caveat interpreting the epidemiological cross-
sectional studies is to know the direction of the causality
between POP exposure and T2DM. A reversed causality
cannot be excluded, meaning that the disease affects the
serum levels of POP. T2DM is associated with a variety of
metabolic changes, which quite conceivably could alter
the metabolism of POPs. T2DM can alter the pharmacok-
inetics of some drugs due to e.g. glycosylation of plasma
proteins or displacement by increased plasma levels of
free fatty acids, or through deteriorated kidney function
[25] and also the activity of cytochrome P450 [26]. T2DM
is also known to cause a dysregulation of fat metabolism,
which in turn might influence the distribution and elimi-
nation of lipophilic compounds such as PCBs and dioxins
[11]. If diabetics have a slower rate of excretion of TCDD
and other POPs, this could account for the observed asso-
ciations with T2DM [4]. The possibility of a slower elimi-
nation of dioxins in T2DM was, however, not supported
by a recent study on Vietnam veterans, in whom no differ-
ence in TCDD half-life was found between diabetic and
non-diabetic patients [27]. Moreover, if T2DM would
slow down the excretion of POPs from the body, time
elapsed since diagnosis of T2DM should be expected to be
positively correlated with CB-153 in serum. Such a corre-
lation was indicated, however not significant, among the
women in the present study. On the other hand among
the men there was a significant negative correlation
between time since T2DM diagnosis and CB-153 in
serum, which speaks against that the T2DM would have
slowed down their POP excretion.
In the present study we used self-reported diabetes, and
had no access to medical records. However, considering
the age distribution, time elapsed since diagnosis and that
only one man and one woman had insulin as single ther-
apy, we feel convinced that almost all of the patients had
a T2DM. Moreover, the prevalence figures in the present
study (6% for men and 5% for men), are well in concord-
ance with was observed in a recent Swedish population
based study on similar age groups (about 7% in men and
about 5% in women) [28]. Moreover, a sensitivity analy-
sis excluding the two diabetic subjects with insulin only
therapy showed that the risk estimates were changed with
<1%.
When calculating BMI, we may have slightly underesti-
mated the height at 25 years of age by measuring the cur-
rent height, but we think that this has only introduced a
minor non-differential misclassification.
Conclusion
This cross-sectional study provides support for the
hypothesis that POP exposure might contribute to type 2
diabetes mellitus. Even if we cannot exclude the possibil-
ity of a reversed causality, the presently observed negative
correlation between time period elapsed since diabetes
diagnosis and CB-153 level in serum, speaks for the
hypothesis of POP as a risk factor.
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